Peripartum cardiomyopathy vs. sulprostone-associated heart failure? A case report and analysis of the literature

Arch Gynecol Obstet. 2013 Dec;288(6):1423-4. doi: 10.1007/s00404-013-2905-x. Epub 2013 May 26.

Authors

Mathilde Vital¹, Christine Lebert, Jean Reignier, Guillaume Ducarme

Affiliation

¹ Department of Obstetrics and Gynecology, Centre Hospitalier Departemental, 85000, La Roche sur Yon, France.

PMID: 23708393
DOI: 10.1007/s00404-013-2905-x

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Cardiomyopathy, Dilated / drug therapy*
Cardiomyopathy, Dilated / etiology
Cardiovascular Agents / therapeutic use*
Dinoprostone / administration & dosage
Dinoprostone / adverse effects
Dinoprostone / analogs & derivatives*
Echocardiography
Female
Heart Failure / diagnosis
Heart Failure / drug therapy*
Heart Failure / etiology
Humans
Peripartum Period
Postpartum Hemorrhage / drug therapy*
Pregnancy
Pregnancy Complications, Cardiovascular / diagnosis
Pregnancy Complications, Cardiovascular / etiology
Pregnancy Complications, Cardiovascular / therapy*
Puerperal Disorders / drug therapy
Treatment Outcome

Substances

Cardiovascular Agents
sulprostone
Dinoprostone